Notice2021-18727
National Center for Advancing Translational Sciences; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 31, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 166 (Tuesday, August 31, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 166 (Tuesday, August 31, 2021)]
[Notices]
[Page 48746]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-18727]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Center for
Advancing Translational Sciences Advisory Council.
The meeting will be open to the public as indicated below. The open
session will be videocast and can be accessed from the NIH Videocasting
and Podcasting website (<a href="http://videocast.nih.gov">http://videocast.nih.gov</a>). Individuals who need
special assistance, such as sign language interpretation or other
reasonable accommodations, should notify the Contact Person listed
below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Advisory Council.
Date: September 23-24, 2021.
Closed: September 23, 2021, 10:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, One Democracy Plaza, 6701 Democracy
Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting).
Open: September 23, 2021, 1:00 p.m. to 5:00 p.m.
Agenda: Report from the Institute Director and other staff.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, One Democracy Plaza, 6701 Democracy
Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting).
Open: September 24, 2021, 1:00 p.m. to 5:00 p.m.
Agenda: To view and discuss Clearance of Concepts.
Place: National Center for Advancing Translational Sciences,
National Institutes of Health, One Democracy Plaza, 6701 Democracy
Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive
Secretary, National Center for Advancing Translational Sciences, One
Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809,
<a href="/cdn-cgi/l/email-protection#f899969699d68a99958b9d819d8f91969fb8969190d69f978e"><span class="__cf_email__" data-cfemail="b1d0dfdfd09fc3d0dcc2d4c8d4c6d8dfd6f1dfd8d99fd6dec7">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice no later than 15 days after the meeting at
<a href="/cdn-cgi/l/email-protection#337d70726760705c465d505a5f7a5d434647735e525a5f1d5d5a5b1d545c45"><span class="__cf_email__" data-cfemail="08464b495c5b4b677d666b61644166787d7c486569616426666160266f677e">[email protected]</span></a>. The statement should include the
name, address, telephone number and when applicable, the business or
professional affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: August 25, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-18727 Filed 8-30-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 31, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.